Clinical Trials Directory

Trials / Completed

CompletedNCT00953355

Metformin and Folate Supplementation in Polycystic Ovary Syndrome (PCOS) Patients

Effects of Metformin With or Without Folate Supplementation on Homocysteine Levels and Endothelium in Women With Polycystic Ovary Syndrome

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University Magna Graecia · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

Context: Metformin administration in women with polycystic ovary syndrome (PCOS) improves hormonal and metabolic patterns with beneficial effects in terms of reproductive outcomes and intermediate cardiovascular disease risk factors. Furthermore, reduced folate and vitamin B12, and increased homocysteine (Hcy) levels have been found in type-2 diabetes mellitus patients treated with metformin. Objective: To evaluate if metformin administration exerts any effects on Hcy levels, and if folate supplementation may improve endothelial structure and function in PCOS patients.

Detailed description

Fifty patients affected by PCOS without additional metabolic or cardiovascular diseases grouped in two age- and body mass index-matched treatment arms. Interventions: A six-month course of metformin (1700 mg daily) plus folic acid (400 microgram daily) (experimental group, n=25) or placebo (control group, n=25) supplementation. In each patient were evaluated: Complete hormonal and metabolic patterns, serum Hcy, folate, vitamin B12, and endothelin-1 (ET-1) concentrations, brachial artery diameter at baseline (BAD-B) and after reactive hyperemia (BAD-RH), flow-mediated dilation (FMD), and intima-media thickness (IMT) on both common carotid arteries.

Conditions

Interventions

TypeNameDescription
DRUGFolate plus metforminA six-month course of metformin (1700 mg daily) plus folic acid (400 microgram daily).
DRUGPlacebo plus metforminA six-month course of metformin (1700 mg daily) plus placebo

Timeline

Start date
2004-01-01
Completion
2007-05-01
First posted
2009-08-06
Last updated
2010-11-03

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00953355. Inclusion in this directory is not an endorsement.